GlassScriptPhysician profile
Michael N Young
NPI 1891938395
$53,283.19
in general payments reported to CMS, 2019-2025
8 companies · $19K in 2025
The $19K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.03 · 2021: $483 · 2022: $12K · 2023: $13K · 2024: $8,111 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $12K · Food and Beverage: $7,565 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,550.00 |
| Travel and Lodging | $12,008.50 |
| Food and Beverage | $7,564.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,437.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $26,898.20 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $12,565.43 | 2019-2025 | Watchman Access System, Ekosonic, Watchman Flx |
| Medtronic, INC. | $10,672.94 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Abbott Laboratories | $3,013.08 | 2021-2025 | Portico, Mitraclip, Navitor |
| Inari Medical, INC. | $100.23 | 2022 | |
| Spectrawave, INC | $19.31 | 2025 | Starlight Imaging Catheter, Hypervue Imaging System |
| Angiodynamics, INC. | $14.00 | 2023 | Alphavac |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.